Cargando…
HIV-1 Integrase-Targeted Short Peptides Derived from a Viral Protein R Sequence
HIV-1 integrase (IN) inhibitors represent a new class of highly effective anti-AIDS therapeutics. Current FDA-approved IN strand transfer inhibitors (INSTIs) share a common mechanism of action that involves chelation of catalytic divalent metal ions. However, the emergence of IN mutants having reduc...
Autores principales: | Zhao, Xue Zhi, Métifiot, Mathieu, Kiselev, Evgeny, Kessl, Jacques J., Maddali, Kasthuraiah, Marchand, Christophe, Kvaratskhelia, Mamuka, Pommier, Yves, Burke, Terrence R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6222646/ https://www.ncbi.nlm.nih.gov/pubmed/30049955 http://dx.doi.org/10.3390/molecules23081858 |
Ejemplares similares
-
Resistance to Integrase Inhibitors
por: Métifiot, Mathieu, et al.
Publicado: (2010) -
Selectivity for strand-transfer over 3′-processing and susceptibility to clinical resistance of HIV-1 integrase inhibitors are driven by key enzyme–DNA interactions in the active site
por: Métifiot, Mathieu, et al.
Publicado: (2016) -
Bicyclic 1-Hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-Containing
HIV-1 Integrase Inhibitors Having High Antiviral Potency against
Cells Harboring Raltegravir-Resistant Integrase Mutants
por: Zhao, Xue Zhi, et al.
Publicado: (2014) -
HIV-1 Integrase Strand Transfer Inhibitors
with Reduced Susceptibility to Drug Resistant Mutant Integrases
por: Zhao, Xue Zhi, et al.
Publicado: (2016) -
HIV-1 Integrase-DNA Recognition Mechanisms
por: Kessl, Jacques J., et al.
Publicado: (2009)